These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24211184)

  • 1. Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation.
    Yao S; Buzo BF; Pham D; Jiang L; Taparowsky EJ; Kaplan MH; Sun J
    Immunity; 2013 Nov; 39(5):833-45. PubMed ID: 24211184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells.
    Raczkowski F; Ritter J; Heesch K; Schumacher V; Guralnik A; Höcker L; Raifer H; Klein M; Bopp T; Harb H; Kesper DA; Pfefferle PI; Grusdat M; Lang PA; Mittrücker HW; Huber M
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15019-24. PubMed ID: 23980171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation.
    Nayar R; Enos M; Prince A; Shin H; Hemmers S; Jiang JK; Klein U; Thomas CJ; Berg LJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2794-802. PubMed ID: 23011795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection.
    Nayar R; Schutten E; Bautista B; Daniels K; Prince AL; Enos M; Brehm MA; Swain SL; Welsh RM; Berg LJ
    J Immunol; 2014 Jun; 192(12):5881-93. PubMed ID: 24835398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription Factor IRF4 Promotes CD8
    Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
    Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
    Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
    J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells.
    Man K; Miasari M; Shi W; Xin A; Henstridge DC; Preston S; Pellegrini M; Belz GT; Smyth GK; Febbraio MA; Nutt SL; Kallies A
    Nat Immunol; 2013 Nov; 14(11):1155-65. PubMed ID: 24056747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential requirements for IRF4 in the clonal expansion and homeostatic proliferation of naive and memory murine CD8
    Miyakoda M; Honma K; Kimura D; Akbari M; Kimura K; Matsuyama T; Yui K
    Eur J Immunol; 2018 Aug; 48(8):1319-1328. PubMed ID: 29745988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells.
    Kurachi M; Barnitz RA; Yosef N; Odorizzi PM; DiIorio MA; Lemieux ME; Yates K; Godec J; Klatt MG; Regev A; Wherry EJ; Haining WN
    Nat Immunol; 2014 Apr; 15(4):373-83. PubMed ID: 24584090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 4 controls effector functions of CD8
    Harberts A; Schmidt C; Schmid J; Reimers D; Koch-Nolte F; Mittrücker HW; Raczkowski F
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33859042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection.
    Nayar R; Schutten E; Jangalwe S; Durost PA; Kenney LL; Conley JM; Daniels K; Brehm MA; Welsh RM; Berg LJ
    PLoS One; 2015; 10(12):e0144826. PubMed ID: 26714260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFN signaling facilitates the development of IL-10-producing effector CD8
    Jiang L; Yao S; Huang S; Wright J; Braciale TJ; Sun J
    Eur J Immunol; 2016 Dec; 46(12):2778-2788. PubMed ID: 27701741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation.
    Peperzak V; Veraar EA; Keller AM; Xiao Y; Borst J
    J Immunol; 2010 Dec; 185(11):6670-8. PubMed ID: 21048108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paths to expansion: Differential requirements of IRF4 in CD8
    Lugli E; Brummelman J; Pilipow K; Roychoudhuri R
    Eur J Immunol; 2018 Aug; 48(8):1281-1284. PubMed ID: 30133745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.
    Li Q; Yan Y; Liu J; Huang X; Zhang X; Kirschning C; Xu HC; Lang PA; Dittmer U; Zhang E; Lu M
    Front Immunol; 2019; 10():2191. PubMed ID: 31572396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.
    Grusdat M; McIlwain DR; Xu HC; Pozdeev VI; Knievel J; Crome SQ; Robert-Tissot C; Dress RJ; Pandyra AA; Speiser DE; Lang E; Maney SK; Elford AR; Hamilton SR; Scheu S; Pfeffer K; Bode J; Mittrücker HW; Lohoff M; Huber M; Häussinger D; Ohashi PS; Mak TW; Lang KS; Lang PA
    Cell Death Differ; 2014 Jul; 21(7):1050-60. PubMed ID: 24531538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 4 deficiency in CD8
    Zou D; Fu J; Guo Z; Chen W
    Immunology; 2020 Dec; 161(4):364-379. PubMed ID: 32892353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation.
    Iborra S; Ramos M; Arana DM; Lázaro S; Aguilar F; Santos E; López D; Fernández-Malavé E; Del Val M
    J Exp Med; 2013 Jul; 210(7):1463-79. PubMed ID: 23776078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4
    Wu J; Zhang H; Shi X; Xiao X; Fan Y; Minze LJ; Wang J; Ghobrial RM; Xia J; Sciammas R; Li XC; Chen W
    Immunity; 2017 Dec; 47(6):1114-1128.e6. PubMed ID: 29221730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.